Sex-Specific Differences in Colon Cancer when Quality Measures Are Adhered to: Results from International, Prospective, Multicenter Clinical Trials Discussion

被引:6
|
作者
Stain, Steven
Bilchik, Anton J.
Collins, J. Craig
Garry, John
Maker, Vijay
机构
[1] Department of Surgical Oncology, John Wayne Cancer Institute, University of California Los Angeles, Santa Monica, CA
[2] Department of Medicine, University of California Los Angeles, Santa Monica, CA
[3] Department of Surgery, University of California Los Angeles, Santa Monica, CA
[4] Department of Surgery, Chaim Sheba Medical Center, Tel Hashomer
[5] Department of Surgical Oncology, Faculty of Medicine, University of Novi Sad, Novi Sad
[6] Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
关键词
D O I
10.1016/j.jamcollsurg.2017.02.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: There is no consensus on the relationship between patient sex and the location, stage, and oncologic outcome of colon cancer (CC). We hypothesized that there is a sex-specific difference in the biology and management of CC. STUDY DESIGN: Our cohort was drawn from a database of patients enrolled in international trials of nodal ultrastaging for nonmetastatic CC. These trials required strict adherence to surgical and pathologic quality measures. Postoperative follow-up included colonoscopy at 1 and 4 years and annual CT scans. Sex-specific differences in tumor biology, location, stage, and recurrence were evaluated by chi-square, Fischer's exact, and independent t-tests. RESULTS: The cohort included 435 males (median age 69 years) and 423 females (median age 70 years). Females had more right-sided (p = 0.03) and earlier T stage (p = 0.05) tumors, but there was no sex-based difference in pathologic grade, total lymph nodes retrieved, nodal positivity (p = 0.47) or lymphovascular invasion (p = 0.45). The overall 4-year disease-free survival (DFS) was comparable in females and males (77.9% and 77.5%, respectively). By multivariate analysis, only nodal positivity and cancer recurrence affected overall survival (OS) (p = 0.008). Neither sex nor primary tumor affected DFS or OS. CONCLUSIONS: This is the first prospective study to demonstrate sex-specific differences in location andTstage ofCC when surgical and pathologicmanagement adhered to strict quality standards. The predominance of right-sided CC in females suggests that flexible sigmoidoscopymay be inadequate for screening and surveillance. Interestingly, earlier stage and right-sided location did not confer a DFS or OS advantage for women. Additional studies are needed to determine why females have a higher propensity for right-sided lesions and a potential difference in CC biology. (C) 2017 by theAmerican College of Surgeons. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:92 / U111
页数:2
相关论文
共 20 条
  • [1] Value of Primary Tumor Gene Signatures in Colon Cancer When National Quality Standards are Adhered to: Preliminary Results of an International Prospective Multicenter Trial
    Anton J. Bilchik
    Zev A. Wainberg
    Aviram Nissan
    Dennis J. Slamon
    Mladjan Protic
    Itzhak Avital
    Hsiao-Wang Chen
    David Chen
    Myung Sim
    David Elashoff
    Alexander Stojadinovic
    Annals of Surgical Oncology, 2015, 22 : 535 - 542
  • [2] Value of Primary Tumor Gene Signature in Colon Cancer when National Quality Standards are Adhered to: Preliminary Results of an International Prospective Multicenter Trial
    Bilchik, A. J.
    Wainberg, Z. A.
    Stojadinovic, A.
    Slamon, D. J.
    Protic, M.
    Halle, D.
    Chen, H.
    Nissan, A.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S13 - S13
  • [3] Value of Primary Tumor Gene Signatures in Colon Cancer When National Quality Standards are Adhered to: Preliminary Results of an International Prospective Multicenter Trial
    Bilchik, Anton J.
    Wainberg, Zev A.
    Nissan, Aviram
    Slamon, Dennis J.
    Protic, Mladjan
    Avital, Itzhak
    Chen, Hsiao-Wang
    Chen, David
    Sim, Myung
    Elashoff, David
    Stojadinovic, Alexander
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 535 - 542
  • [4] Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial Discussion
    Glasgow, Sean
    Bilchik, Anton
    Neumayer, Leigh Anne
    Cirocco, William
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (01) : 140 - 141
  • [5] Sex-Specific Factors Affecting Quality of Life After Major Trauma: Results of a Prospective Multicenter Registry-Based Cohort Study
    Freigang, Viola
    Mueller, Karolina
    Ernstberger, Antonio
    Alt, Volker
    Herrmann-Johns, Anne
    Baumann, Florian
    HEALTHCARE, 2025, 13 (04)
  • [6] Sex-specific differences and risk factors for 30-day mortality in acute pulmonary embolism - results from the Serbian University Multicenter Pulmonary Embolism registry
    Matijasevic, Jovan
    Miric, Milica
    Vucicevic-Trobok, Jadranka
    Pekovic, Sandra
    Andrijevic, Ilija
    Dzudovic, Boris
    Subotic, Bojana
    Obradovic, Slobodan
    VOJNOSANITETSKI PREGLED, 2021, 78 (12) : 1263 - 1272
  • [7] International prospective multi-center clinical trial with adherence to surgical and pathological quality measures: Influence of body mass index (BMI) on outcome in colon cancer
    Protic, M.
    Bilchik, A.
    Nissan, A.
    Knezevic, S. Usaj
    Kukic, B.
    Kresoja, M.
    Veljkovic, R.
    Zivojinov, M.
    Stojadinovic, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] GENDER-SPECIFIC DIFFERENCES OF THE EARLY AND LONG-TERM ONCOSURGICAL OUTCOME IN GASTRIC CANCER (CA) - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY FOR QUALITY ASSURANCE AND CONTRIBUTION TO RESEARCH ON CLINICAL CARE
    Mahendran, Pirashanna
    Steinert, Ralf
    Otto, Ronny
    Lippert, Hans
    Gastinger, Ingo
    Croner, Roland
    Meyer, Frank
    GASTROENTEROLOGY, 2020, 158 (06) : S1579 - S1580
  • [9] International differences in prostate cancer treatment outcomes correlate with clinical stage and pretreatment prostate-specific antigen level: Results of an ongoing, prospective, international trial program
    See, WA
    Wirth, MP
    McLeod, DG
    Iversen, P
    JOURNAL OF UROLOGY, 2003, 169 (04): : 445 - 445
  • [10] Quality improvement measures and focused pathological staging without adjuvant chemotherapy in stage II colon cancer: interim results from a National Cancer Institute sponsored international prospective multi-center trial
    Bilchik, Anton J.
    Protic, Mladjan
    Nissan, Aviram
    Wainberg, Zev
    Steele, Scott R.
    Avital, Itzhak
    Stojadinovic, Alexander
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E45 - E45